Differentiating chronic obstructive pulmonary disease from asthma

Journal of the American Academy of Nurse Practitioners

Volumn 20, Issue 9, 2008, Pages 445-454

  Kuebler, Kim K ^a,d   Buchsel, Patricia C ^b   Balkstra, Cynthia R ^c  

^a BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Georgia Regional Hospital   (United States)

^d NONE   (United States)

Author keywords

Asthma; Bronchodilators; COPD; Spirometry

Indexed keywords

ANTIINFLAMMATORY AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; LEUKOTRIENE RECEPTOR BLOCKING AGENT; THEOPHYLLINE;

ANAMNESIS; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIFFERENTIAL DIAGNOSIS; EPIDEMIOLOGY; FORCED EXPIRATORY VOLUME; HOSPITALIZATION; HUMAN; NURSE ATTITUDE; NURSE PRACTITIONER; NURSING ASSESSMENT; ORGANIZATION AND MANAGEMENT; PEAK EXPIRATORY FLOW; PHYSICAL EXAMINATION; SPIROMETRY; UNITED STATES;

ADRENERGIC BETA-AGONISTS; ANTI-INFLAMMATORY AGENTS; ASTHMA; BRONCHODILATOR AGENTS; CAUSALITY; CHOLINERGIC ANTAGONISTS; DIAGNOSIS, DIFFERENTIAL; FORCED EXPIRATORY VOLUME; HUMANS; LEUKOTRIENE ANTAGONISTS; MEDICAL HISTORY TAKING; NURSE PRACTITIONERS; NURSE'S ROLE; NURSING ASSESSMENT; PEAK EXPIRATORY FLOW RATE; PHYSICAL EXAMINATION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; SPIROMETRY; THEOPHYLLINE; UNITED STATES;

EID: 51149113273     PISSN: 10412972     EISSN: 17457599     Source Type: Journal    
DOI: 10.1111/j.1745-7599.2008.00332.x     Document Type: Article

References (52)

1. American Thoracic Society 1991). Lung function testing: Selection of reference values and interpretative strategies. American Review of Respiratory Disorders, 144, 1202 1218.
2. Barnes, P. J 1998). Pharmacology of airway smooth muscle. American Journal of Respiratory Critical Care Medicine, 158 (Pt. 3 S123 S132.
3. Barnes, P. J 2000). Mechanisms in COPD: Differences from asthma. Chest, 117 (2 Suppl 10S 14S.
4. Barr, R. G., Bourbeau, J., Camargo, C. A. Ram, F. S 2005). Inhaled tiotropium for stable chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews, (2 CD002876.
5. Bone, R. C 1996). Goals of asthma management. A step-care approach. Chest, 109, 1056 1065.
6. Buist, A. S 2003). Similarities and differences between asthma and chronic obstructive pulmonary disease: Treatment and early outcomes. European Respiratory Journal, 39 (Suppl 30S 35S.
7. Burge, P. S., Calverley, P. M., Jones, P. W., Spencer, S., Anderson, J. A. Maslen, T. K 2000). Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronc obstructive pulmonary disease: The ISOLDE trial. British Medical Journal, 320, 1297 1303.
8. Castro, M., Schechtman, K. B., Halstead, J. Bloomberg, G 2001). Risk factors for asthma morbidity and mortality in a large metropolitan city. Journal of Asthma, 38, 625 635.
9. Celli, B. R. MacNee, W 2004). Standards for the diagnosis and treatment of patients with COPD: A summary of the ATS/ERS position paper. European Respiratory Journal, 23, 932 946.
10. Decramer, M., Gosselink, R., Bartsch, P., Lofdahl, C. G., Vincken, W., Dekhuijzen, R., et al 2005). Effect of treatments on the progression of COPD: Report of a workshop held in Leuven, March 11-12, 2004. Thorax, 60, 343 349.
11. Doherty, D. E 2004). The pathophysiology of airway dysfunction. American Journal of Medicine, 117 (Suppl. 12A 11S 23S.
12. Dolovich, M. B., Ahrens, R. C., Hess, D. R., Anderson, P., Dhand, R., Rau, J. L., et al 2005). Device selection and outcomes of aerosol therapy: Evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology. Chest, 127, 335 371.
13. Edmonds, M. L., Camargo, C. A., Jr., Pollack, C. V., Jr. Rowe, B. H 2002). The effectiveness of inhaled corticosteroids in the emergency department treatment of acute asthma: A meta-analysis. Annuals of Emergency Medicine, 40, 145 154.
14. Fletcher, C. Peto, R 1977). The natural history of chronic airflow obstruction. British Medical Journal, 1, 1645 1648.
15. Foresi, A. Paggiaro, P 2003). Inhaled corticosteroids and leukotriene modifiers in the acute treatment of asthma exacerbations. Current Opinion in Pulmonary Medicine, 9, 52 56.
16. Global Initiative for Asthma 2006). Global strategy for asthma management and prevention. Retrieved August 1, 2007, from http://www.ginasthma.org
17. Global Initiative for Chronic Obstructive Lung Disease 2006). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Retrieved August 1, 2007, from http://www.goldcopd.org
18. Gold, D. R. Wright, R 2005). Population disparities in asthma. Annual Review of Public Health, 26, 89 113.
19. Gross, N. J 1991). The influence of anticholinergic agents on treatment for bronchitis and emphysema. American Journal of Medicine, 91, 11S 12S.
20. Janson, S. Lazarus, S. C 2002). Where do leukotriene modifiers fit in asthma management? Nurse Practitioner, 27, 19, 23 14, 26 19 quiz 30-11.
21. Jeffery, P. K 2000). Comparison of the structural and inflammatory features of COPD and asthma: Giles F. Filley lecture. Chest, 117, 251S 260S.
22. Kesten, S 2001). Chronic obstructive pulmonary disease in managed-care setting. Disease Management and Health Outcomes, 9, 589 599.
23. Kochanek, K. D., Murphy, S. L., Anderson, R. N. Scott, C 2004). Deaths: Final data for 2002. National Vital Statistics Report, 53 (5 1 115.
24. Krieger, B 2002). When wheezing may not mean asthma. Post Graduate Medicine, 112, 342 351.
25. Kuebler, K. Patajo, R 2006). Pulmonary disease. In K. Kuebler, D. Heidrich P. Esper (Eds Palliative and end-of-life care clinical practice guidelines (2nd ed., pp. 157 180). St. Louis, MO : Elsevier.
26. Kumar, S. D., Brieva, J. L., Danta, I. Wanner, A 2000). Transient effect of inhaled fluticasone on airway mucosal blood flow in subjects with and without asthma. American Journal Respiratory and Critical Care Medicine, 161, 918 921.
27. Lung Health Study Research Group 2000). Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease. New England Journal of Medicine, 343, 1902 1909.
28. Mannino, D. M. Davis, K. J 2006). Lung function decline and outcomes in an elderly population. Thorax, 61, 472 477.
29. Mannino, D. M., Homa, D. M., Akinbami, L. J., Ford, E. S. Redd, S. C 2002). Chronic obstructive pulmonary disease surveillance - United States, 1971-2000. MMWR Surveillance Summaries, 51 (6 1 16.
30. Mannino, D. M., Reichert, M. M. Davis, K. J 2006). Lung function decline and outcomes in an adult population. American Journal Respiratory Critical Care Medicine, 173, 985 990.
31. McNee, W 2006). Standards for the diagnosis and treatment of patients with COPD. Proceedings of the American Thoracic Society, 3, 539 542.
32. National Asthma Education and Prevention Program 2002). Guidelines for the diagnosis and management of asthma. Retrieved August 1, 2007, from http://www.cdc.gov/nchs/products/pubs/pubd/hestats/asthma/asthma.htm
33. National Center for Health Statistics 2002). Asthma prevalence, health care use and mortality, 2002. Retrieved August 1, 2007, from http://www.cdc.gov/nchs/products/pubs/pubd/hestats/asthma/asthma.htm
34. National Lung Health Education Program 1998). Strategies in preserving lung health and preventing COPD and associated diseases. Chest, 113 (2 Suppl 123S 163S.
35. Niewoehner, D. E., Rice, K., Cote, C., Paulson, D., Cooper, J. A., Jr., Korducki, L., et al 2005). Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: A randomized trial. Annuals of Internal Medicine, 143, 317 326.
36. O'Donnell, D. E., Hernandez, P., Aaron, S., Bourbeau, J., Marciniuk, D., Hodder, R., et al 2003). Canadian Thoracic Society COPD Guidelines: Summary of highlights for family doctors. Canadian Respiratory Journal, 10, 183 185.
37. Petty, T. L 2000). Scope of the COPD problem in North America: Early studies of prevalence and NHANES III data: Basis for early identification and intervention. Chest, 117 (Suppl. 2 326S 331S.
38. Ram, F. S., Jardin, J. R., Atallah, A., Castro, A. A., Mazzini, R., Goldstein, R., et al 2005). Efficacy of theophylline in people with stable chronic obstructive pulmonary disease: A systematic review and meta-analysis. Respiratory Medicine, 99, 135 144.
39. Rennard, S. I 2004). Treatment of stable chronic obstructive pulmonary disease. Lancet, 364, 791 802.
40. Rodrigo, G. Rodrigo, C 1999). Corticosteroids in the emergency department therapy of acute adult asthma: An evidence-based evaluation. Chest, 116, 285 295.
41. Rodrigo, G. J 2003). Inhaled therapy for acute adult asthma. Current Opinion in Allergy and Clinical Immunology, 3, 169 175.
42. Sin, D. D., McAlister, F. A., Man, S. F. Anthonisen, N. R 2003). Contemporary management of chronic obstructive pulmonary disease: Scientific review. JAMA, 290, 2301 2312.
43. Strunk, R. C. Bloomberg, G. R 2006). Omalizumab for asthma. New England Journal of Medicine, 354, 2689 2695.
44. Szafranski, W., Cukier, A., Ramirez, A., Menga, G., Sansores, R., Nahabedian, S., et al 2003). Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease. European Respiratory Journal, 21, 74 81.
45. Tashkin, D. Kesten, S 2003). Long-term treatment benefits with tiotropium in COPD patients with and without short-term bronchodilator responses. Chest, 123, 1441 1449.
46. Tashkin, D. P 2005). Is a long-acting inhaled bronchodilator the first agent to use in stable chronic obstructive pulmonary disease? Current Opinion in Pulmonary Medicine, 11, 121 128.
47. Tashkin, D. P. Cooper, C. B 2004). The role of long-acting bronchodilators in the management of stable COPD. Chest, 125, 249 259.
48. Tinkelman, D. G., Price, D. B., Nordyke, R. J. Halbert, R. J 2006). Misdiagnosis of COPD and Asthma in Primary Care Patients 40 Years of Age and Over. Journal of Asthma, 43, 75 80.
49. van Noord, J. A., Bantje, T. A., Eland, M. E., Korducki, L. Cornelissen, P. J 2000). A randomised controlled comparison of tiotropium and ipratropium in the treatment of chronic obstructive pulmonary disease. The Dutch Tiotropium Study Group. Thorax, 55, 289 294.
50. Vincken, W., van Noord, J. A., Greefhorst, A. P., Bantje, T. A., Kesten, S., Korducki, L., et al 2002). Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium. European Respiratory Journal, 19, 209 216.
51. Voelkel, N. F. Agusti, A 2004). COPD at the 2004 9th European Pulmonary Summit. Pulmonary Pharmacological Therapeutics, 17, 249 251.
52. Warman, K., Silver, E. J. Wood, P. R 2006). Asthma risk factor assessment: What are the needs of inner-city families? Annuals of Allergy Asthma Immunology, 97 (Suppl. 1 S11 S15.